Northwest Biotherapeutics (OTCMKTS:NWBO) Stock Price Crosses Below 200-Day Moving Average of $0.58

Northwest Biotherapeutics, Inc. (OTCMKTS:NWBOGet Free Report)’s stock price crossed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $0.58 and traded as low as $0.57. Northwest Biotherapeutics shares last traded at $0.65, with a volume of 2,426,029 shares.

Northwest Biotherapeutics Trading Up 13.2 %

The stock has a market capitalization of $724.04 million, a PE ratio of -8.06 and a beta of -0.14. The firm has a 50 day moving average price of $0.54 and a 200 day moving average price of $0.58.

Northwest Biotherapeutics (OTCMKTS:NWBOGet Free Report) last issued its quarterly earnings results on Wednesday, August 9th. The biotechnology company reported ($0.01) earnings per share (EPS) for the quarter. The business had revenue of $0.20 million during the quarter.

Northwest Biotherapeutics Company Profile

(Get Free Report)

Northwest Biotherapeutics, Inc, a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer.

Further Reading

Receive News & Ratings for Northwest Biotherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Northwest Biotherapeutics and related companies with's FREE daily email newsletter.